High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. [electronic resource]
Producer: 20090216Description: 380-8 p. digitalISSN:- 1460-2091
- Adenine -- administration & dosage
- Adult
- Amino Acid Substitution -- genetics
- Anti-HIV Agents -- administration & dosage
- CD4 Lymphocyte Count
- Drug Resistance, Viral
- Female
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Humans
- Lamivudine -- administration & dosage
- Male
- Middle Aged
- Mutation, Missense
- Nevirapine -- administration & dosage
- Organophosphonates -- administration & dosage
- Tenofovir
- Treatment Outcome
- Viral Load
- Viral Proteins -- genetics
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.